TruLite Health Secures $7 Million in Funding for Health Equity Solutions


TruLite Health, a company focused on health equity solutions, has closed a $7 million Series A financing round.

The funding will be used to accelerate the organization’s commercial growth, enhance client support resources and expand product offerings, the company said in a Tuesday (Aug. 29) press release.

TruLite Health entered the commercial market with the introduction of the Truity platform, a solution that addresses clinical bias and provides multi-level interventions at the point of care within an integrated workflow system, according to the press release. The platform has received significant early interest, leading to the need for expansion in sales, support and services staff to meet the growing demand.

Alan Roga, MD, CEO and co-founder of TruLite Health, said in the release that addressing systemic clinical bias is crucial for providing equitable care and improving outcomes, quality and cost. Roga expressed enthusiasm about the positive reception the solution has received from the industry and the opportunity to collaborate with leading healthcare organizations in tackling systemic clinical bias as a complement to existing Social Determinants of Health (SDoH) initiatives.

The Truity platform is powered by the world’s largest curated health equity knowledge base, according to the press release. Integrated within the electronic medical record (EMR) workflow, the system matches a patient’s health record and associated social data sets with the Truity knowledge base, providing clinicians and care teams with personalized information and recommendations for diverse patients.

Robert Adelson, managing director of Osage Venture Partners, which led the funding round, emphasized the importance of TruLite Health’s approach to remediating clinical bias at the point of care, stating that it can dramatically improve outcomes for diverse patient populations. Adelson also highlighted in the press release the TruLite Health team’s deep domain expertise and successful track record, having previously built one of the largest telehealth companies in the market.

Innovation around electronic medical records is powering new experiences in healthcare, Jeff Lin, president of InstaMed, a J.P. Morgan company, and global co-head of healthcare payments at J.P. Morgan, told PYMNTS’ Karen Webster in an interview posted in April.

“There is a broad spectrum of ways to get access to care that I think is profound for patients,” Lim added at the time. “You’ll start seeing this with the Internet of Things, health wearables, and so on.”